Fred Hutch public health researchers Drs. Scott Ramsey and Veena Shankaran welcomed stakeholders to the 2024 Value in Cancer Care Summit held November 15, thanking them for 10 years of hard work to improve cancer care for patients.
Abstract. Antibody–drug conjugates (ADC) represent one of the most rapidly expanding treatment modalities in oncology, with 11 ADCs approved by the FDA and more than…
The combination of sorafenib tosylate, valproic acid, and sildenafil demonstrated activity in a phase 2 trial of patients with high-grade glioma.
Recent research in classifying subtypes of small cell lung cancer is bringing renewed hope for treatment advances. To learn more, we spoke with Carl Gay,…
Press release to promote updated ASTRO clinical guideline for radiation therapy to treat patients with locally advanced rectal cancer
Capivasertib plus abiraterone and ADT improved rPFS in PTEN-deficient metastatic hormone-sensitive prostate cancer.
This component of the American Cancer Society National Lung Cancer Roundtable (ACS NLCRT) strategic plan examines the impediments to successful adoption, dissemination, and implementation of…
State Cancer Profiles is an interactive map engine produced in collaboration between the National Cancer Institute and Centers for Disease Control and Prevention. It was…
Nature Reviews Cancer – Androgen receptor (AR) signalling plays an important role in several cancers beyond prostate cancer. This Review highlights the context-dependent functions of…
Learn more about and submit your abstract to the AACR Annual Meeting 2025, held April 25-30, 2025, in Chicago, Illinois.
On November 15, 2024, the FDA approved revumenib for the treatment of adult and pediatric patients aged ≥1 year with R/R acute leukemia with a…
